5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF
申请人:Genentech, Inc.
公开号:US20160237086A1
公开(公告)日:2016-08-18
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.
本文描述了化学式(00A)的化合物以及作为Janus激酶抑制剂的使用方法。
5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS
申请人:F. Hoffmann-La Roche AG
公开号:EP3145929B1
公开(公告)日:2021-01-13
US9346815B2
申请人:——
公开号:US9346815B2
公开(公告)日:2016-05-24
US9604984B2
申请人:——
公开号:US9604984B2
公开(公告)日:2017-03-28
[EN] 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS<br/>[FR] COMPOSÉS 5-CHLORO -2-DIFLUOROMÉTHOXYPHÉNYL PYRAZOLOPYRIMIDINE UTILISÉS EN TANT QU'INHIBITEURS DE JAK
申请人:HOFFMANN LA ROCHE
公开号:WO2015177326A1
公开(公告)日:2015-11-26
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein. Claimed uses are the treatment of inflammation and asthma.